Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRI-CP: Convalescent Plasma in High-risk COVID-19
NCT04425837Phase 3Unknown
- Sponsor
- Fundación Santa Fe de Bogotá
- Start
- Jul 2020
- Primary completion
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by Fundación Santa Fe de Bogotá. Status: unknown.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04425837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425837.